Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now

COVID-19 Vaccine Update | Iran says Pfizer vaccine batch expected from US benefactors

Iran has struggled to stem the worst virus outbreak in the Middle East, which has infected over 1.2 million people and killed nearly 55,000.

December 28, 2020 / 09:47 PM IST
Source: Reuters

Source: Reuters

An unidentified group of U.S.-based philanthropists plans to send 150,000 doses of the Pfizer vaccine to Iran in the coming weeks, Iranian media reported Monday, in a step that could bring the hardest-hit country in the Middle East closer to inoculating its citizens against the coronavirus.

Details remained scarce in the report by semiofficial Tasnim news agency. It quoted the chief of the country's Red Crescent Society as saying he expects the vaccine created by American drug maker Pfizer and its German partner BioNTech to be imported by Jan. 19 based on coordination with a group of benefactors in the U.S."

Italy turns to flower power to help spread COVID-19 vaccine message

Iran has struggled to stem the worst virus outbreak in the Middle East, which has infected over 1.2 million people and killed nearly 55,000.

Karim Hemmati, the Red Crescent director, said his organization plans to receive an additional 1 million vaccine doses, which on Sunday the semiofficial news website reported would come from China. The vaccines will be offered to citizens free of charge, Hemmati said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Officials have said previously that importing the Pfizer vaccine, which must be shipped and stored at minus 70 degrees Celsius (minus 94 degrees Fahrenheit), poses major logistical challenges for Iran.

Iran has signed up for COVAX, an international program designed to distribute coronavirus vaccines to participating countries regardless of their wealth. It's run in part by Gavi, The Vaccine Alliance. which says the U.S. Treasurys Office of Foreign Asset Control has already issued a license for Iran to take part. The U.S. Treasury has not reacted to Iran's participation.

The chief of Iran's central bank, Abdolnasser Hemmati, told state TV last week that Iran had received approval to transfer a $244 million payment through an unnamed bank in a third country to obtain nearly 17 million doses of vaccines from COVAX. He did not provide further details, such as which vaccine or how the money would be sent. Under COVAX rules, Iran could at a maximum order enough doses to vaccinate half of its 82 million people.

President Hassan Rouhani said Saturday that Iran would refuse to make the COVAX payment through U.S. financial institutions for fear of confiscation. Since the start of the pandemic, political figures in Iran have pushed anti-American conspiracy theories about the spread of the virus and vaccine production, dismissing the prospect of U.S. assistance.

Who trusts you? Wherever you found our money you stole it," Rouhani said.

He added that Iran would not participate in human trials of foreign-made vaccines, vowing to provide the country with imported and locally produced vaccines.

Iran's homemade vaccine is due to enter a Phase 1 clinical trial soon, enrolling 54 volunteers across the country to receive two shots, state-run IRNA news agency reported. Iran's vaccine research has gained urgency as officials allege that heavy American sanctions will hamper the Islamic Republics mass inoculation efforts.

Although Iran retains routes to vaccines despite sanctions, including through its participation in COVAX, international banks and financial institutions are reluctant to deal with Iran for fear of American penalties.

Meanwhile, hard-line officials in Iran's Revolutionary Guard have rejected the use of foreign-made vaccines altogether. Last week, deputy chief of the Revolutionary Guard, Gen. Mohammad Reza Naghdi, said the Guard does not recommend the injection of any foreign vaccine candidates based on genetic material known as messenger RNA, which carries the instructions for cells to make proteins.
Associated Press
first published: Dec 28, 2020 09:46 pm
ISO 27001 - BSI Assurance Mark